Boothbay Fund Management LLC Has $6.52 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Boothbay Fund Management LLC raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 21.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 281,161 shares of the company’s stock after buying an additional 49,588 shares during the quarter. Boothbay Fund Management LLC owned about 0.17% of Option Care Health worth $6,523,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of OPCH. JPMorgan Chase & Co. grew its holdings in Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company’s stock valued at $35,065,000 after purchasing an additional 344,875 shares during the period. Graypoint LLC bought a new position in shares of Option Care Health during the fourth quarter worth $1,161,000. Charles Schwab Investment Management Inc. grew its holdings in shares of Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock valued at $58,235,000 after buying an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. grew its holdings in shares of Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after buying an additional 18,992 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Option Care Health in the 4th quarter valued at $327,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Trading Up 2.2 %

NASDAQ:OPCH opened at $32.90 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a market cap of $5.40 billion, a P/E ratio of 27.65, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. The business has a 50 day moving average price of $33.36 and a two-hundred day moving average price of $28.76.

Wall Street Analysts Forecast Growth

OPCH has been the subject of a number of research analyst reports. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Monday, April 21st. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JMP Securities reaffirmed a “market outperform” rating and issued a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.75.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.